UNITED THERAPEUTICS Corp (UTHR) income statement
UTHRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/3022% above fair value
$577.34−6.76 (-1.16%)
Close on Nov 18, 2026Market cap $24.76BP/E 20.7Yield –
UNITED THERAPEUTICS Corp income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 86.1%
- Operating margin
- 44.4%
- Net margin
- 41.6%
- Return on equity, FY2025
- 19.7%
Financial strength
- Current ratio
- 5.73
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 296.7%
Valuation
- P/E ratio
- 20.7
- Price to sales
- 7.85
- Price to book
- 3.87
- Dividend yield
- –
See a number that looks wrong?